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ABSTRACT.
Purpose: Subthreshold micropulse laser (SMPL) has been increasingly used for
the treatment of different retinal and choroidal macular disorders. However, the
exact mechanisms of action have not yet been clearly defined. Therefore, we aimed
to examine the role of SMPL treatment in the modulation of oxidant/antioxidant
systems, apoptosis and autophagy in the mice eyes.
Methods: A specific laser contact lens for retina was positioned on the cornea of
40 mice (20 young and 20 old) in order to focus the laser on the eye fundus for
SMPL treatment. Within 6 months, 20 animals received one treatment only,
whereas the others were treated three times. Eye specimens underwent histological
analysis and were used for thiobarbituric acid reactive substances (TBARS) and
glutathione (GSH) quantification, as well as for the superoxide dismutase 1
(SOD1) and the selenoprotein thioredoxin reductase 1 (TrxR1) expression
evaluation. Western blot was performed for nitric oxide synthase (NOS) subtypes
detection and to examine changes in apoptotic/autophagy proteins expression.
Results: SMPL treatment reduced TBARS and increased GSH and SOD1 in the
mice eyes. It also reduced cytochrome c, caspase 3 expression and activity and
cleaved caspase 9, and increased Beclin 1, p62 and LC3b. The effects were more
relevant in the elderly animals.
Conclusion: Our results showed that SMPL therapy restored the oxidant/
antioxidant balance within retinal layers and modulated programmed forms of cell
death. Further studies may confirm these data and could evaluate their relevance in
clinical practice.
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Introduction
Subthreshold micropulse laser (SMPL)
treatment is currently used in different
retinal diseases, including diabetic
macular oedema, central serous chori-
oretinopathy and macular oedema sec-
ondary to retinal vein branch occlusion
(BRVO) (Vujosevic et al. 2010, 2013,
2015; Maruko et al. 2017).
The molecular mechanisms involved
in these conditions include increased
oxidative stress, which increases cellular
permeability and tight junction disrup-
tion (Amoaku et al. 2015). Also, apop-
tosis and endothelial and inducible
nitric oxide synthase (NOS)-dependent
nitric oxide (NO) release could be
involved as pathogenetic factors (Zhang
et al. 2014).
Thus, although the exact mecha-
nisms of reducing oedema by laser
therapy have not so far been clearly
examined, a plausible role would be
played by the modulation of retinal
oxygenation/metabolism and oxidative
stress (Vujosevic et al. 2013; Amoaku
et al. 2015).
However, the use of the suprathresh-
old laser photocoagulation is associ-
ated with many side-effects, including
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chorioretinal atrophy, choroidal neo-
vascularization, formation of fibrotic
scars and reduced retinal sensitivity.
Those complications can be limited by
changing laser parameters, such as
power and wavelength, spot size of
retinal irradiance, pulse duration and
the use of micropulse technique (Main-
ster 1999; Ferrara et al. 2003; Kiire
et al. 2011).
Hence, the laser treatment technique
has turned over the years into a more
advanced, effective and safe therapy for
retinal disorders. The new technique
takes advantage of subthreshold,
micropulses of controlled laser radia-
tions that are selectively absorbed by
the retinal pigment epithelium (RPE)
and therefore can elicit therapeutic
effects with minimal or no retinal
damage (Ohkoshi & Yamaguchi 2010;
Luttrull et al. 2012; Li et al. 2015). As
mentioned above, however, available
data regarding the cellular mechanisms
are scarce.
We therefore planned to examine the
histological and molecular effects of
micropulse laser in young and old mice
eyes. Particular attention was paid to
the balance between oxidant/antioxi-
dant system, NOS subtypes and
markers of apoptosis and autophagy
expression/activation.
Materials and Methods
The experiments were performed in 40
male C57BL/6 mice. Twenty mice were
3 months old (young) (Lutty 2017) at
the beginning of the treatment, whereas
the others were 12 months old (old)
(Dutta & Sengupta 2016). All mice
were housed in a room at a constant
temperature of 25°C on a 12-/12-hr
light/dark cycle with food and water
available ad libitum. All experiments
were conducted in accordance with
local ethical standards, approved by
national guidelines (legislative decree
(DLGS), January 27, 1992, license 116)
and in accordance with ARRIVE
guidelines and with ‘Guide for the Care
and Use of Laboratory Animals’
(National Institutes of Health publica-
tion 8023, 1978 revision).
For laser treatment, a specific laser
contact lens for retina (Ocular Fundus
5.4 LASER lens; Ocular Instruments
New Tech SpA, Vimodrone, Milan,
Italy) was positioned on the cornea in
order to focus the laser on the eye fundus.
Mice were previously anaesthetized with
intramuscular ketamine (50 mg/kg;
Intervet, Segrate, Milan, Italy), xylazine
(5 mg/kg; Bayer, Varese, Italy) and ace-
promazine (0.5 mg/kg; Bayer) adminis-
trated 15 min before the procedure. One
drop of 1% tropicamide (Novartis
Farma, Origgio, Varese, Italy) and
2.5% phenylephrine hydrochloride
(Novartis Farma) were topically applied
30 min prior to laser micropulse proce-
dure to achieve pupillary dilation. A
micropulse infrared laser 810 nm (Ocu-
light SLx; Iridex, Corp, Mountain View,
CA, USA) positioned on a specific slit
lamp was used. The laser parameters
established through a ‘burn test’ were as
follows: spot size, 500 lm; pulse time,
75 ms and 50 mWatt until barely visible
retinal whitening in a continuous mode.
The laser power was duplicated in the
micropulse mode with application of
confluent spots. In all eyes, a visible burn
was obtained with 50 mWatt with con-
tinuous wave mode; therefore,
100 mWatt power was used in micro-
pulse mode at 5% in order not to have
clinically visible treatment. Laser treat-
ment was performed on all visible retina
fromoptic disc till periphery, trying to be
more confluent as possible. At least an
areaof 2.0 mmradius from the optic disc
(four laser spot diameters) was treated
(Fig. 1).
As shown in Fig. 2, mice were
divided into two groups: only one-
treatment group (n = 20) and three-
treatment group (n = 20). In the only
one-treatment group, the laser treat-
ment was applied to the left eye at
month 1 (T1). In the three-treatment
group, the laser treatment was applied
to the left eye once every 3 months for
6 months from month 1 (T1) to month
6 (T3). The time interval of 3 months
for retreatment was chosen as per usual
clinical practice and based on data
from randomized clinical trial (Vujose-
vic et al. 2015). Each treatment lasted
about 5 min. The nontreated eye of
each mouse was used as a control.
At 1 month after the last treatment,
all animals were sacrificed through
cervical dislocation and eyes were
gently removed and either placed in
phosphate-buffered saline (PBS; Sigma,
Milan, Italy) on ice for molecular
analysis or fixed in 2.5% glutaralde-
hyde in phosphate buffer 0.13 M
(Sigma) for histology.
Tissue preparation for molecular analysis
Using a dissecting microscope, seven
eyes for each experimental group were
incised at the posterior margin of the
limbus and the cornea, and the iris and
lens were removed. Thereafter, the
retinas were lifted away from the eyecup
by forceps and sectioned for further
analysis (Wei et al. 2016). In particular,
for TBARS and Western blot analysis,
retinas were lysed in a buffer (1 M Tris
base, 1 M NaCl, 0.5 M EDTA, 10%
nonyl phenoxypolyethoxylethanol and
10% Triton X-100; Sigma) containing
1:100 protease inhibitors, 1:200 sodium
orthovanadate and 1:1000 phenyl-
methylsulfonyl fluoride (Sigma) and
homogenized on ice by using homoge-
nizer (Microtec Co., Ltd., Chiba,
Japan). The lysates were centrifuged
at 14 000 g for 20 min at 4°C, and
the supernatant was used for the
analysis.
Fig. 1. Schematic representation of the eye fundus treated by laser.
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For glutathione (GSH) quantifica-
tion, retinas were washed many times
with PBS (Sigma) to remove any red
blood cells. Thereafter, retinas were
homogenized in 5 ml of cold buffer
(MES buffer; Sigma) per gram tissue.
The homogenized tissues were cen-
trifuged at 10 000 g for 15 min at
4°C, and supernatant was used for the
analysis.
Optical microscopy
Histological analysis was performed in
the same area treated with laser by the
same researcher blinded to the experi-
mental protocol on three eyes from
each experimental group. The posterior
segment (that includes choriocapillaris,
Bruch’s membrane, RPE and neu-
roretina) of the eye was fixed in
osmium tetroxide in 0.1 M cacodylate
buffer (Sigma) for 1 h, subjected to
dehydration, then embedded in epoxy
resin and sectioned into 1-lm semithin
sections and analysed by optical micro-
scopy.
Thiobarbituric acid reactive substances
(TBARS) assay
For TBARS quantification, the manu-
facturer’s instructions were followed
(Cayman Chemical, Ann Arbor, MI,
USA), as previously performed (Gros-
sini et al. 2014; Surico et al. 2015).
Briefly, 100 ll of each sample was
complemented with an equal volume of
a sodium dodecyl sulphate solution,
supplemented with 4 ml of a colour rea-
gent and vortexed. The samples were
then incubated at 95°C for 60 min,
placed in an iced bath to stop the
reaction for 10 min and centrifuged
(10 min at 1600 g at 4°C). Thereafter,
150 ll of each sample was loaded in a
96-well plate and the absorbance was
measured with a spectrometer (BS1000
Spectra Count, San Jose, CA, USA) at
530 nm. The results were presented as
micromolar concentrations of malondi-
aldehyde (MDA).
GSH assay
GSH measurements were performed
with a specific kit (Cayman Chemical),
as previously performed (Grossini
et al. 2014; Surico et al. 2015; De Cilla
et al. 2017).
The supernatant was treated with an
equal volume of metaphosphoric acid
Fig. 2. Schematic representation of the experimental protocol.
Fig. 3. Effects of SMPL on glutathione (GSH), malonyldialdeide (MDA) and thioredoxin
reductase 1 (TrxR1) retinal content in young (A, C, E) and old (B, D, F) mice. The results are
shown as the mean  SD of four or seven different experiments. NT: nontreated eye; 1T: one laser
treatment; 3T: three laser treatments. Square brackets indicate significance between groups.
*p < 0.0001.
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(final concentration 5%; Sigma-
Aldrich Corp., St. Louis, MO, USA)
for 5 min and centrifuged at 2000 g for
at least two min. The supernatant was
collected and supplemented with 50 ll
per ml of 4 M solution of tri-
ethanolamine (Sigma). Fifty ll of the
samples was transferred to a 96-well
plate where GSH was detected follow-
ing the manufacturer’s instructions
through a spectrometer (BS1000 Spec-
tra Count) at excitation/emission wave-
lengths of 405–414 nM. GSH was
expressed as nanomoles in samples
with 1.5 mg of protein/ml.
Thioredoxin reductase colorimetric assay
Thioredoxin reductase 1 (TrxR1) activ-
itywasmeasuredwitha specifickit (Cay-
man Chemical), by monitoring the
nicotinamide adenine dinucleotide
phosphate (NADPH)-dependent reduc-
tion of DTNB (5,50-dithiobis(2-nitro-
benzoic) acid) in the presence or absence
of aurothiomalate (ATM), a specific
TrxR1 inhibitor. Briefly, 20 ll of each
samplewas transferred to a 96-well plate
where TrxR1 was detected. The reac-
tions were initiated by adding 0.24 mM
NADPHand 3 mMDTNBand the rate
of increase in absorbance was measured
at 405 nm, following the manufac-
turer’s instructions, through a spec-
trometer (BS1000 Spectra Count). The
amount of NADPH-dependent activity
that was inhibited by ATM is attributed
to TrxR1. TrxR1 activity was expressed
as nmol DTNB reduction/min per mg
protein.
Caspase 3 activity assay
The effect of micropulse laser treatment
on caspase 3 activity was determined
by using a commercially available
Mouse Casp 3 (Caspase 3) ELISA kit
(Fine Test, Wuhan, Hubei, China),
following the manufacturer’s instruc-
tions. Briefly, 100 ll of each sample,
diluted 1:10 in wash buffer (tissue
homogenate concentration was 10–
100 ng/ml), was added into test sample
wells and incubated at 37°C for
90 min. Samples were aspirated and
washed two times with wash buffer and
incubated with 100 ll of biotin-labelled
antibody working solution for 60 min
at 37°C. After removal of the antibody
solution, the wells were washed again
and incubated with 100 ll of
HRP-streptavidin conjugate (SABC)
Fig. 4. Histological analysis of mice eyes. An example taken from 3 different eyes for each
experimental group is shown. In 1 and 2, the histological analysis of retinas from the nontreated
eye of each treated animal is shown. In 3 and 4, the histological analysis of retinas from the three-
treatment animal group is shown. A1-D1: all retinal layers. Cb = ciliary body; On = optic nerve;
GCL = ganglionic cell layer, IPL = inner plexiform layer, INL = inner nuclear layer,
ONL = outer nuclear layer, IS = photoreceptor inner segments, OS = photoreceptor outer
segment, RPE = retinal pigmented epithelium, Ch = choroids, S = sclera.
Fig. 5. Effects of SMPL on retinal superoxide dismutase 1 (SOD1) and Akt activation in young
(A, C) and old (B, D) mice. In (A, B) expression of SOD1; in (C, D) activation of Akt.
Densitometric analysis and an example of Western Blot, taken from seven different experiments,
are shown. Abbreviations are as in previous Figures. The results are the means  SD of seven
different experiments. Square brackets indicate significance between groups. *p < 0.0001.
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working solution, for 30 min at 37°C.
After the aspiration of the SABC
working solution, blue colour was
developed by adding 90 ll of TMB
substrate into each well. The chro-
mogen solution was incubated for 15–
30 min in the dark. The reaction was
stopped by adding 50 ll of stop solu-
tion, and the yellow colour developed
was read using a microplate reader at
450 nm.
Nitrate and nitrite colorimetric assay
For total nitrate and nitrite quantifica-
tion, the manufacturer’s instructions
were followed (Cayman Chemical).
Briefly, tissue samples were homoge-
nized and centrifuged at 10 000 g for
20 min. The supernatant was ultracen-
trifuged at 10 000 g for 30 min and
then ultrafiltered by using 30 kDa
molecular weight cut-off filter. For
total nitrate and nitrite measurement,
40 ll of each filtrate was diluted in
40 ll assay buffer, and 80 ll of each
diluted sample was transferred to a 96-
well plate. Ten ll of the enzyme cofac-
tor mixture and 10 ll of the nitrate
reductase mixture were added in each
well (standards and unknowns). The
plate was covered and incubated at
room temperature for 3 h. Finally,
50 ll of Griess reagent R1, followed
by the addition of 50 ll of Griess
reagent R2, was added in each well.
After 10 min, the total nitrate and
nitrite production was measured
through a spectrometer (BS1000 Spec-
tra Count), reading the absorbance at
540 nm. The results were presented as
micromolar concentrations of nitrate
and nitrite.
Western blotting
Protein concentrations were deter-
mined by using the bicinchoninic acid
(Pierce, Rockford, IL, USA) assay.
Cell lysates (30 lg protein each sample)
dissolved in Laemmli buffer 59, boiled
for 5 min, were resolved in 15%
sodium dodecyl sulphate (Sigma) poly-
acrylamide gel electrophoresis (Bio-
Rad Laboratories, Hercules, CA,
USA), and after electrophoresis, trans-
ferred to polyvinylidene fluoride mem-
branes (Bio-Rad Laboratories) which
were incubated overnight at 4°C with
specific primary antibodies: anti-phos-
pho-Akt (1:1000; Ser473; Cell Sig-
nalling Technologies, Danvers, MA
USA), anti-Akt (1:1000; Cell Signalling
Technologies), anti-phospho-endothe-
lial NOS (eNOS; 1:1000; Ser1177; Cell
Signalling Technologies), anti-eNOS
(1:1000; Cell Signalling Technologies),
anti-inducible NOS (iNOS; 1:500;
Santa Cruz Biotechnology, Inc., CA,
USA), anti-cytochrome c (1:500;
Sigma), anti-cleaved caspase 9
(1:1000; Cell Signalling Technologies),
anti-caspase 3 (1:500; Santa Cruz
Biotechnology), anti-Beclin 1 (Bcn1;
1:500; Santa Cruz Biotechnology),
anti-MAP LC3 a/b (1:500; H-47; Santa
Cruz Biotechnology), anti-superoxide
dismutase 1 (SOD-1; 1:500; Santa Cruz
Biotechnology) and anti-p62 (1:500;
CABRU, Arcore, Milan, Italy). The
membranes were washed and then
incubated with horseradish peroxi-
dase-coupled goat anti-rabbit IgG
(Sigma), peroxidase-coupled rabbit
anti-goat IgG and horseradish peroxi-
dase-coupled goat anti-mouse IgG
(Sigma) for 45 min, and were
developed through a nonradioactive
method using Western Lightning
Chemiluminescence (PerkinElmer Life
and Analytical Sciences, Waltham,
MA, USA). Phosphorylated protein
expression was calculated as a ratio
towards specific total protein expres-
sion or b-actin (1:5000; Sigma)
detection.
Statistics
All data were recorded using the Insti-
tution’s database. Statistical analysis
was performed using STATVIEW ver-
sion 5.0.1 for Microsoft Windows (SAS
Institute Inc., Cary NC, USA). Data
were checked for normality before
statistical analysis. One-way ANOVA
followed by Bonferroni post hoc tests
were used to examine changes in dif-
ferent groups of animals. Data are
expressed as means  standard devia-
tion (SD). A value of p < 0.05 was
considered statistically significant.
Fig. 6. Effects of SMPL on retinal apoptosis in young (A, C) and old (B, D) mice. In (A, B)
expression of caspase 3. Densitometric analysis and an example of Western Blot, taken from seven
different experiments, are shown. In (C, D) caspase 3 activity is shown. Abbreviations are as in
previous Figures. The results are the means  SD of seven different experiments. Square brackets
indicate significance between groups. *p < 0.0001.
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Results
As shown in Figs 3–9, young and old
mice showed different basal values of
oxidant/antioxidant system markers;
young having higher antioxidants,
eNOS and pAkt, while old having
higher TBARS, iNOS and apoptosis.
No differences were observed in
histological or molecular analysis in
the fellow eye between two treatment
groups. Thus, only the results found in
the right eyes of three-treatment animal
group were shown.
SMPL reduced MDA and increased
GSH and TrxR1 activity without any
histological retinal changes (Figs 3,4).
The antioxidant effects of SMPL
were confirmed by Western blot that
showed an increase in SOD1 in either
the one- or three-treatment group of
animals (Fig. 5A,B). Also, the expres-
sion of Akt, which would exert protec-
tive effects against peroxidation, was
found to be augmented by laser treat-
ments (Fig. 5C,D).
In addition, SMPL reduced the
markers of apoptosis (Figs 6,7) and
increased the autophagic ones (Fig. 8),
with particular interest to LC3 b.
Finally, both NOS subtypes retinal
content were restored by the laser
treatment that increased eNOS and
reduced iNOS (Fig. 9). It is to note
that the total nitrate+nitrite amount
was also increased.
As shown by the above Figures, all
the effects of SMPL were related to the
number of treatments.
Discussion
The results of this study showed that
the SMPL is a treatment option which
is able to modulate the oxidant/antiox-
idant balance within retinal layers,
counteract apoptosis and activate
autophagy. These findings could be of
particular relevance since so far the
mechanisms responsible for the protec-
tive effects elicited by laser therapy
have not yet been clarified.
It is notable that the eyes of young
and old mice expressed different
amounts of products of lipid peroxida-
tion, expressed by MDA, and of GSH,
SOD1 and TrxR1 showing the existence
of changes in the balance of oxidant and
antioxidant systems as a response to the
ageing process. Hence, SOD1 has been
reported to be important in protecting
the retina from oxidative stress induced
by paraquat and hyperoxia, and by
ageing. In addition, SOD1(/) mice
were found to develop many features of
patients with age-related macular
degeneration (AMD) (Dong et al.
2009). As has been also reported by
Sies et al. (2017), the activation of the
selenoprotein TrxR1 could be involved
in the regulation of nuclear factor E2-
related factor 2 (Nrf2), a peptide
belonging to a family of transcription
factors inducing antioxidant and detox-
ication enzymes.
Our study confirmed previous find-
ings about the safety of SMPL. Hence,
SMPL is less harmful than continuous
wave lasers because, since the pulses
are very short, heat can be dissipated
within tissue. For the low-intensity/
high-density 810 diode laser treatment
employed in the current study, prior
clinical studies have shown the absence
of retinal damage (Luttrull et al. 2005,
2012; Luttrull & Sinclair 2014; Luttrull
2016a; Luttrull & Margolis 2016b), and
improvement of visual function and
electrophysiology (Luttrull 2016a,
2018a; Luttrull et al. 2018b). The so-
called high-density treatment (by deliv-
ering continuous spots on the retina)
has been demonstrated to be more
effective than the treatment with space
among spots, thus with lower number
(Lavinsky et al. 2011).
The treatment of left mice eyes
with micropulse laser reduced MDA,
increased GHS level, SOD1 and TrxR1.
Furthermore, those effects, which were
evident with the very first treatment in
particular in the old eyes, were related
to the number of treatments. This issue
needs to be further examined to confirm
Fig. 7. Effects of SMPL on retinal apoptosis in young (A, C) and old (B, D) mice. In (A, B)
expression of cytochrome c; in (C, D), expression of cleaved caspase 9. Densitometric analysis and
an example of Western Blot, taken from seven different experiments, are shown. Abbreviations are
as in previous Figures. The results are the means  SD of seven different experiments. Square
brackets indicate significance between groups. *p < 0.0001.
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if this observation is really the result of a
cumulative effect caused by SMPL or if
it is simply related to a more efficacious
wearing off after 1 treatment in com-
parison with that observed after more
treatments. On the ground of current
understanding of the main therapeutic
pathway via RPE/heat-shock protein
(HSP) activation, the proximity effect
rather than total dosage could also be
hypothesized to account for our find-
ings.
It is notable that the right eyes were
not affected by the micropulse laser
irrespective of the number of treat-
ments, which excluded any possible
action of laser on the nontreated eye.
In physiological conditions, ROS are
normally produced by the RPE of the
macula, which has a high metabolic
demand. It is notable, however, that
those structures have robust antioxi-
dant systems that protect them from
the oxidative stress (Tate et al. 1995;
Ruia et al. 2016; Lutty 2017).
Any alteration in the oxidant/an-
tioxidant balance may represent the
trigger factor at basis of diabetic
retinopathy and of macular oedema
caused by BRVO (Van der Schaft et al.
1991).
It is interesting to compare our
findings with those of prior studies.
The stimulation of RPE by a low-dose
pulse laser induced hypoxia-inducible
factor 1-alpha (HIF1-a) mRNA and
activated an inflammatory response
below the acute inflammatory thresh-
old, which could cause tissue injury; in
particular, 2 weeks post-treatment,
bone marrow-derived cells homing to
the RPE-choroid cells were found
(Caballero et al. 2017). Moreover,
sublethal micropulse photothermal
stimulation was shown to upregulate
heat-shock protein 70 (Hsp70) in RPE,
a protein belonging to the Hsp family
members, which functions as molecular
chaperones in response to cellular stress
like hyper- or hypothermia, hyper- or
hypoxia, or oxidative stress (Sramek
et al. 2011; Inagaki et al. 2015; Kern
et al. 2018).
Since Hsp could counteract the
activity of apoptotic and inflammatory
pathways that cause cellular damage,
upregulation of Hsp70 expression
induced by laser irradiation would play
an important role in reducing macular
oedema following clinical laser ther-
apy. It is notable that the beneficial
effects elicited by Hsp70 in the preven-
tion of retinal degenerative disorders
could be related to the keeping of
cellular redox status by modulation of
glutathione-related enzymes.
Thus, although not examined yet, we
could hypothesize that the beneficial
effects elicited by SMPL are due to
changes in HIF1-a and Hsp70 retinal
content which might activate forward
signalling, possibly accounting for the
long-term effects of laser treatment.
Those alterations could also be specu-
lated to be involved in the observed
differences of responses found between
one single treatment and repetitive
treatments.
Changes in nitric oxide (NO) release
could also play an important role in the
pathophysiology of diabetic retinopa-
thy and diabetic macular oedema, by
Fig. 8. Effects of SMPL on retinal autophagy in young (A, C, E) and old (B, D, F) mice. In (A, B)
expression of Beclin 1 (Becn1); in (C, D) expression of p62; in (E, F), expression of LC3 a/b.
Densitometric analysis and an example of Western Blot, taken from seven different experiments,
are shown. Abbreviations are as in previous Figures. The results are the means  SD of seven
different experiments. Square brackets indicate significance between groups. *p < 0.0001.
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interfering with retinal circulation, the
metabolism of photoreceptors and
RPE proliferation (Goldstein et al.
1996; Pacher et al. 2005).
NO is synthetized by three different
isoforms of NOS: eNOS, neural NOS
and iNOS. While NO at low concen-
tration such as that produced by eNOS
has been widely reported to maintain
good endothelial function, NO pro-
duced in large amounts by iNOS has
been regarded as a toxic agent (Awata
et al. 2004).
Thus, changes of NO release by
NOS/iNOS impairment may represent
a pathogenic factor in the acceleration
of retinal layers injuries and neovascu-
larization associated with hypergly-
caemia, hypertension and ageing
(Awata et al. 2004).
In our study, the SMPL treatment
restored the levels of eNOS and iNOS,
which were differently expressed in the
retina of young and old mice, by
increasing the former and decreasing
the latter. Our results are in line with
recent findings showing that the mod-
ulation of angiogenesis by laser treat-
ment could involve the inhibition of
iNOS-related NO release by RPE and/
or choroid cells (Jiang et al. 2017).
Thus, although not fully examined,
NOS expressed by those cell types
could result from thermal laser effects
on the RPE, which is the primary
thermal target of SMPL.
In addition, retinal protection exerted
by the SMPL could arise, in part, from
laser-induced normalization of NOS
subtypes’ expression. It is noteworthy
that nitrates and nitrites content in the
retinal tissue was augmented by SMPL.
Since the synthesis of nitrate and nitrite
could arise from eNOS-related NO
release by oxidation reactions, our
observations would support the finding
of eNOS activation in response to
SMPL (Omar et al. 2016).
On the ground of previous findings
showing that pan-retinal photocoagu-
lation would inhibit the initiation and
maintenance required for active neo-
vascularization through changes of
metalloproteinases and their inhibitors
balance, further studies would be
planned to better address this issue, as
well (Flaxel et al. 2007).
Our observations about programmed
forms of cell death were in agreement
with previous data that showed both an
increase in apoptosis and a decrease in
the retinal expression of many autop-
hagymarkers in oldmice (Dunaief et al.
2002). Hence, in our older animals,
cytochrome c, caspase 9 and caspase 3
expression and activation were higher,
whereas Beclin 1, p62 and LC3 a/b
expression were lower than in young
mice.
The role of autophagy in maintaining
normal retinal function has been widely
demonstrated (Rodrıguez-Muela et al.
2013). Moreover, changes in the autop-
hagic pathway were reported to lead to
an increased mitochondrial injury and
ROS generation (Soufi et al. 2012;
Barber & Baccouche 2017; Zhang et al.
2017).
As observed for the oxidant/antiox-
idant system in our study, apoptosis
and autophagy were also modulated by
the SMPL treatment, with apoptosis
inhibition and autophagy activation.
The keeping of a balance between those
Fig. 9. Effects of SMPL on retinal nitric oxide synthase (NOS) content and nitrate and nitrite
production in young (A, C, E) and old (B, D, F) mice. In (A, B), endothelial NOS (eNOS)
activation; in (C, D) expression of inducible NOS (iNOS). Densitometric analysis and an example
of Western Blot, taken from seven different experiments, are shown. In (E, F) nitrite and nitrate
retinal content is shown. Abbreviations are as in previous Figures. The results are the
means  SD of seven different experiments. Square brackets indicate significance between
groups. *p < 0.0001.
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programmed forms of cell death could
be hypothesized to play a key role in
maintaining the physiological retinal
function.
Hence, SMPL reduced cytochrome
c, cleaved caspase 9 and caspase 3
expression and activation, and
increased well-known markers of
autophagy activation (Wei et al. 2017)
like Beclin 1, p62 and LC3b, as shown
by the decreased LC3a/b ratio. Thus,
the keeping of a balance between those
programmed forms of cell death
exerted by SMPL could be hypothe-
sized to be involved in normalizing
retinal function.
The phosphatidylinositol 3-kinase–
Akt (PI3K/AKT) signalling pathway,
which is involved in the control of cell
survival, differentiation, growth and
apoptosis, is activated when retinal
layers are exposed to oxidative stress.
In particular, it has been found that
PI3K/AKT can exert retinal protection
against light- or hydrogen peroxide-
induced apoptosis by modulation of
mitochondrial apoptosis signalling
(Zhu et al. 2015). The results of our
study would be in agreement with
previous observations. Hence, the acti-
vated form of Akt was reduced in the
old animals in comparison with the
young ones. It is notable that as
mentioned above, those animals also
had higher MDA and lower SOD1,
GSH and TrxR1.
Overall, our results lend insight into
the physiologic responses to retinal
laser treatments sublethal to the
retina, such as SMPL, as a clinically
safe therapeutic option showing a
reduction of oxidative stress, which
was accompanied by the modulation
of programmed forms of cell death
and Akt. Since our findings are in
agreement with previous clinical
knowledge about this issue (Luttrull
2016a, 2018a; Luttrull et al. 2018b),
they could strengthen the use of
SMPL as treatment for the manage-
ment of other retinal disorders char-
acterized by changes in oxidant/
antioxidant balance and of apoptosis
and autophagy.
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